Correlation Engine 2.0
Clear Search sequence regions


  • blood (1)
  • hemophilia (6)
  • humans (1)
  • japan (1)
  • patients (8)
  • platelet count normal (1)
  • sepsis (1)
  • Sizes of these terms reflect their relevance to your search.

    Acquired hemophilia A (AHA) is an acquired autoantibody (inhibitor) against blood coagulation factor VIII (FVIII) that significantly reduces FVIII activity and causes a bleeding tendency. Immune acquired coagulation factor deficiency. The peak age of onset is in the 70s. In Japan, which has an aging society, the number of reports has recently been increasing, and it should be noted that AHA is a bleeding disease that can occur in the elderly. Examined 5 cases of AHA that were experienced in our hospital. The FVIII inhibitor level, APTT, underlying disease, treatment history, and outcome were retrospectively examined using medical records. The age of onset was 76-93 years. At the time of diagnosis, the Hb (mg/dL) value was 6.1-10.3, the APTT was 75.6-203.2 seconds, the FVIII inhibitor value (BU/mL) was 18-686, and the platelet count was within the normal range in all cases. Bleeding control was possible using a bypass hemostatic agent in 4 patients. All patients underwent immunosuppressive therapy. Two patients were discharged alive and 3 patients died. The cause of death was infectious disease in all cases. The total prednisolone-equivalent dose of the deceased patients was 1,240-3,206 mg; one patient was treated with cyclophosphamide and was treated with dexamethasone. Long-term immunosuppressive therapy is expected to increase the risk of infection in elderly patients. The risk assessment of AHA treatment-related bloodstream infections is insufficient, and it will be necessary to accumulate data and consider appropriate assessments and countermeasures.

    Citation

    Yasuo Aota, Kagehiro Amano, Teruhisa Kurata, Arisa Sutoh, Mitsuru Moriyama, Nayuta Namioka, Masahiro Okabe, Keiko Shinozawa, Tomohisa Yokoyama, Akihiko Gotoh. Examination of the effect of immunosuppressive therapy on acquired hemophilia A in elderly patients with bloodstream infections]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics. 2022;59(1):90-95

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35264539

    View Full Text